In the Lab Claudia López Lloreda STAT Plus: Researchers use machine learning to translate brain signals from a paralyzed patient into text
Exclusive Olivia Goldhill STAT Plus: Athira Pharma CEO placed on leave amid allegations of altered images in her research papers
First Opinion Dana P. Goldman and Darius Lakdawalla STAT Plus: FDA’s approval of aducanumab paves the way for ‘more momentous’ Alzheimer’s breakthroughs
Health Sara Reardon Covid-19 gave scientists an opening to better understand how brain disorders arise
Biotech Adam Feuerstein STAT Plus: STAT+ Conversations: A conversation on the latest in neuroscience and CNS drug development
In the Lab Usha Lee McFarling STAT Plus: New monkey model of Alzheimer’s disease may accelerate search for human treatments
In the Lab Usha Lee McFarling STAT Plus: ‘It looks like a spaghetti bowl’: Scientists reveal a precise structure in a fabled worm’s tangled brain
Biotech Matthew Herper STAT Plus: Experts encouraged by Denali’s early results in study of Hunter syndrome drug
In the Lab Eric Boodman STAT Plus: Genetic reprogramming rejuvenates nerve cells and restores vision in mice
Health Meghana Keshavan A MacArthur ‘genius’ will likely use his grant to support his wife’s work — in the name of science
Health Tech Rebecca Robbins and Erin Brodwin STAT Plus: Elon Musk’s Neuralink unveils prototype of brain implants — and looks toward clinical trials
The Readout LOUD Damian Garde and Adam Feuerstein The FDA’s chaotic week, Trump’s effect on science, and Musk’s big reveal
Rebecca Robbins, Casey Ross and Erin Brodwin STAT Health Tech: Elon Musk’s secretive brain implants startup & Verily’s move into health insurance
Special Report Erin Brodwin and Rebecca Robbins STAT Plus: As Elon Musk’s Neuralink prepares to draw back the curtain, ex-employees describe rushed timelines clashing with science’s slow pace
Health Hyacinth Empinado and Theresa Gaffney Watch: What day is it? How pandemic stress alters your perception of time
Biotech Damian Garde and Matthew Herper STAT Plus: Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects
In the Lab Theresa Gaffney STAT Plus: How does exercise benefit the aging brain? Transfusing blood from active mice into sedentary ones suggests an answer
Biotech Adam Feuerstein STAT Plus: Yumanity Therapeutics, Merck strike deal aimed at developing new medicines for neurodegenerative disease
In the Lab Juliet Isselbacher By tricking mice into sensing fake smells, scientists decode how the brain recognizes scent
In the Lab Shraddha Chakradhar STAT Plus: Researchers develop a non-invasive way to manipulate neurons to study behavior
In the Lab Megan Thielking Scientists turn organs transparent — and use a new technique to capture 3D pictures of what’s inside
In the Lab Eric Boodman The vodka trial: In search of a treatment for vocal disorders, a researcher puts patient anecdotes to the test
In the Lab Sharon Begley Brain-imaging study shows ‘hot spot’ that may explain why African Americans feel greater pain
In the Lab Sharon Begley A ‘landmark’ achievement: Scientists trace full wiring diagram of the fly brain’s core
First Opinion Donna Jackson Nakazawa Microglia: a new target in the brain for depression, Alzheimer’s, and more?
In the Lab Sharon Begley Scientists show mice an Orson Welles movie, then disprove dogma about how vision works
In the Lab Sharon Begley Research using brains-in-a-dish forces a radical rethinking of Huntington’s disease
Health Andrew Joseph A new Alzheimer’s therapy is approved in China, delivering a surprise for the field but also questions